Metastatic pattern and its prognostic value in well-differentiated neuroendocrine tumors

被引：0
|
作者：
Chen, L. [1 ]
Yan, X. [1 ]
Liu, M. [1 ]
Lin, Y. [1 ]
He, Q. [1 ]
Luo, Y. [1 ]
Wang, Y. [1 ]
Chen, M. H. [1 ]
Zeng, Z. [1 ]
Zhang, N. [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
neuroendocrine tumor; metastasis; progression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D13
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [1] METASTATIC PATTERN AND ITS PROGNOSTIC VALUE IN WELL-DIFFERENTIATED NEUROENDOCRINE TUMORS
    Chen, Luohai
    Yan, Xu
    Liu, Man
    Lin, Yuan
    He, Qiao
    Luo, Yanji
    Wang, Yu
    Chen, Minhu
    Zeng, Zhirong
    Zhang, Ning
    GASTROENTEROLOGY, 2023, 164 (06) : S1192 - S1193
  • [2] Effect of Dacarbazine Chemotherapy in Well-Differentiated Neuroendocrine Tumors
    Mueller, D.
    Rinke, A.
    Gress, T.
    NEUROENDOCRINOLOGY, 2012, 96 : 50 - 50
  • [3] Risk Stratification of Well-Differentiated Rectal Neuroendocrine Tumors
    Zhang, Y.
    Chen, L.
    Zhang, Y.
    Guan, X.
    Pan, Y.
    Chen, M. H.
    Chen, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 116 - 116
  • [4] Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study
    Huang, Xi-Tai
    Xie, Jin-Zhao
    Chen, Liu-Hua
    Cai, Jian-Peng
    Chen, Wei
    Liang, Li-Jian
    Zhang, Ning
    Yin, Xiao-Yu
    GASTROENTEROLOGY REPORT, 2023, 11
  • [5] Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review
    Pasricha, Gurleen
    Padhi, Parikshit
    Daboul, Nour
    Monga, Dulabh K.
    CLINICAL THERAPEUTICS, 2017, 39 (11) : 2146 - 2157
  • [6] The exceptionally rare phenomenon of well-differentiated colon neuroendocrine tumors
    Al-Toubah, Taymeyah
    Strosberg, Jonathan
    JOURNAL OF NEUROENDOCRINOLOGY, 2025,
  • [7] Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Dasari, Arvind
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [8] Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
    Ito, Tetsuhide
    Honma, Yoshitaka
    Hijioka, Susumu
    Kudo, Atsushi
    Fukutomi, Akira
    Nozaki, Akira
    Kimura, Yasutoshi
    Motoi, Fuyuhiko
    Isayama, Hiroyuki
    Komoto, Izumi
    Hisamatsu, Seiichi
    Nakajima, Akihiro
    Shimatsu, Akira
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (04) : 499 - 508
  • [9] Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
    Tetsuhide Ito
    Yoshitaka Honma
    Susumu Hijioka
    Atsushi Kudo
    Akira Fukutomi
    Akira Nozaki
    Yasutoshi Kimura
    Fuyuhiko Motoi
    Hiroyuki Isayama
    Izumi Komoto
    Seiichi Hisamatsu
    Akihiro Nakajima
    Akira Shimatsu
    Investigational New Drugs, 2017, 35 : 499 - 508
  • [10] Primary metastatic well-differentiated neuroendocrine tumor arising in a tailgut cyst
    Woehlke, M.
    Sauer, J.
    Dommisch, K.
    Goerling, S.
    Valdix, A.
    Hinze, R.
    PATHOLOGE, 2011, 32 (02): : 165 - 167
12345